COMP <GO>
IMMP vs MIRA // DIVIDEND YIELD & FCF PAYOUT SAFETY
Immutep Limited (NASDAQ) VS. MIRA Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: IMMP 1
— MIRA 1
■ METRIC PARITY
LAST: $3.33 (+0.30%) • MKT CAP: $24.5M
dividend-safety
0.00%
LAST: $0.57 (+2.79%) • MKT CAP: $24.0M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMMP VS. MIRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMMP | MIRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -19.41% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 23.1 | 34.3 | -11.15 | MIRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.5M | $24.0M | $524.1K | IMMP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMMP REV | MIRA REV | IMMP GROSS % | MIRA GROSS % | IMMP FCF | MIRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$4.7M |
| FY 2024 | — | $0 | — | — | — | -$5.6M |
| FY 2023 | — | $0 | — | — | — | -$4.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMMP // BETA —
MIRA // BETA —